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Abstract
Background: The physiological characteristics of muscle activity and the assessment of muscle
strength represent important diagnostic information. There are many devices that measure muscle
force in humans, but some require voluntary contractions, which are difficult to assess in weak or
unconscious patients who are unable to complete a full range of voluntary force assessment tasks.
Other devices, which obtain standard muscle contractions by electric stimulations, do not have the
technology required to induce and measure reproducible valid contractions at the optimum muscle
length.
Methods: In our study we used a newly developed diagnostic device which measures accurately
the reproducibility and time-changed-variability of the muscle force in an individual muscle. A total
of 500 in-vivo measurements of supra-maximal isometric single twitch contractions were carried
out on the musculus adductor pollicis of 5 test subjects over 10 sessions, with ten repetitions per
session. The same protocol was performed on 405 test subjects with two repetitions each to
determine a reference-interval on healthy subjects.
Results: Using our test setting, we found a high reproducibility of the muscle contractions of each
test subject. The precision of the measurements performed with our device was 98.74%. Only two
consecutive measurements are needed in order to assess a real, representative individual value of
muscle force. The mean value of the force of contraction was 9.51 N and the 95% reference interval
was 4.77–14.25 N.
Conclusion: The new myograph is a highly reliable measuring device with which the adductor
pollicis can be investigated at the optimum length. It has the potential to become a reliable and valid
tool for diagnostic in the clinical setting and for monitoring neuromuscular diseases.
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Background
In both men and animals, the correct wiring of the nerv-
ous system to discrete motor units during development
determines the functional outcome of the muscle as
assessed by the contraction force. Some traditional meth-
ods of patient evaluation, including neurological assess-
ment, manual muscle testing and rating scales, involve
subjective elements and lack the sensitivity and reproduc-
ibility needed to detect small but meaningful changes in
the progression of the disease, reflecting deterioration or
therapeutic efficacy. In diseases affecting the neuromuscu-
lar unit, the objective assessment of the quality of the
muscle's contraction force for individual patients is made
using a variety of electrophysiological tests including elec-
tromyography (EMG) and nerve conduction recordings.
The assessment of these physiological characteristics gen-
erates a clear topographical representation of the spread of
the disease and enables the monitoring of the progression
of nerve-muscle diseases. However, in the clinical setting,
the EMG devices have limitations in the diagnosis of
myopathies, since they require a conscious and compliant
patient and the recorded potentials do not directly corre-
late with muscle strength.
Manual testing without any measuring device is the stand-
ard method of assessment of muscle strength in most clin-
ics. This method has certain disadvantages [1] because it
relies on subjective assessment by the clinician and is thus
inadequate to quantify small changes in muscle strength.
Several objective methods for the study of muscle force in
humans, using a diverse range of devices to measure the
contraction of the muscle, have been developed and are
applied in medicine and medical science. However, these
devices have their own limitations that make them a less
than ideal clinical diagnostic device. Some measure only
maximal voluntary contractions [1-9], which is sub-opti-
mal since patients are often too weak and unable to com-
plete a full range of motivation in voluntary force
assessment tasks. Moreover, these devices rely on volun-
tary contractions, cannot examine individual muscles and
have no pre-stretching mechanism to bring the muscles to
their optimal length. Therefore the position of the extrem-
ity and the length of the muscle depend on the character-
istics of the measuring equipment. Although good
reproducibility may be achieved [3,6,7,9], the results can-
not lead to absolute, valid statements on the examined
muscle, independent of measurement conditions (which
include variable patient compliance, undefined summa-
tion of muscle vectors and artificial pre-stretching posi-
tion).
Devices which rely upon electrically stimulated standard
contractions are characterized by inadequately defined
axle-adjustments [10-12]. Some of these devices have lim-
ited degrees of freedom preventing adequate adaptation
for different test subjects sizes [2,13], while others are on
a sloped physiological axis [2]. Some devices have a set-
ting design which impedes the contraction [14]. These
devices also have restrictions in their pre-stretching mech-
anism. Some have no pre-stretching mechanism at all,
while others define the pre-stretching optimum by the
stretching force not by the stretching length [10,12].
Devices which do assess the muscle length use graded
mechanisms, either roughly graded [14] or with finer gra-
dations obtained by using a step-motor [11,13], and have
no variable pre-stretching mechanism. Additionally, the
imprecise axle-adjustment and the constant extremity-set-
ting lead to an ill-defined and variable contraction force
vector in pre-stretching [11-14].
An ideal measurement device should be able to precisely
determine and quantify a neuromuscular deficit. For clin-
ical in-vivo measurements, a device as reproducible and
valid as the in-vitro model is required. The device should
be able to examine single muscles and to precisely define
the physiological rotation axis of the limb, the force vector
and the muscular length of an individual test subject. Fur-
thermore, the optimum length of the muscle should be
easy to determine and reproduce. All these conditions
must be kept constant during the examination. To moni-
tor progress of a disease and its response to treatment, it is
also important to make sure that the sensitivity of the tests
is sufficient to detect changes in the muscle's contraction.
This implies that the variability in the measurements is
known and it is small enough to allow changes to be rec-
ognized [15]. We suggest that our myograph [16] has all
the characteristics described above, including those which
are necessary to warrant a high standard for these clinical
measurements.
The first aim of our study was to evaluate the quality of
our newly developed myograph by assessing the repro-
ducibility of the measurements of muscle force within and
between testing sessions. The second aim was to deter-
mine reference values and the reference interval for the
maximal force of the adductor pollicis indirectly stimulated
with a single electrical supra-maximal pulse.
Methods
Device
The contraction force of musculus adductor pollicis was
recorded using a specially developed myograph. This
device was described in detail earlier [16]. Briefly, the core
parts of the apparatus are the elements for axle-adjust-
ment, for extremity-setting and for pre-stretching the mus-
cle to its optimal length as well as the elements for
stimulating the nerve, and for measuring muscle length
and muscle force.BioMedical Engineering OnLine 2007, 6:49 http://www.biomedical-engineering-online.com/content/6/1/49
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An extremity-setting module was chosen for the examina-
tion of the right musculus adductor pollicis. A laser beam
running directly through the axle of the apparatus was
projected onto the anatomical landmarks of the hand of
the test subject, ensuring that physiological rotation axis
was made congruent with the axle of the apparatus. When
the hand was in the correct position, mounted cushion
pads were moved towards arm and hand by electro-
motors. A smoothly adjustable pre-stretching mechanism
enabled the muscle to be pre-stretched to any physiologi-
cal length, and then locked into place isometrically. Each
position of the cushion pads and of the stopping mecha-
nism was registered with electrical measurement record-
ers. This information was stored and the mechanic
elements could then be moved automatically into posi-
tion when that same test subject was examined again at a
later time.
Subjects, Place, Time
The study were carried out in accordance with the Helsinki
Declaration of the World Medical Association and
approved by the local Ethics Committee. All experiments
were performed in the Department of Anesthesiology of
Hannover Medical School. The first part of the study was
carried out on 5 healthy voluntary test subjects, two
women and three men. They were between 20 and 30
years old, the range of body height was 1.57 m to 1.96 m,
the range of weight 45 kg to 103 kg. All of the test subjects
were right handed, had no history of neuromuscular dis-
order or injury, and gave free, written informed consent to
participate in this study. The second part of the study was
performed on 405 healthy test subjects (aged 22–41). The
contraction force was determined twice on each test sub-
ject.
Protocol
Reproducibility: We examined 5 test subjects. For every
subject, 100 datasets were collected. The examinations for
each subject were performed over 10 sessions by three
randomly selected investigators. There was an interval of
1 to 5 days between two consecutive sessions. The exami-
nations started between 4 and 5 p.m. During each session
an experiment was performed 10 times per test subject. To
ensure the quality of the setting module of the device and
to guarantee identical experimental conditions within
and between the sessions, the extremity of the test subject
was taken off the myograph after each recording. For each
new recording, the extremity was replaced, readjusted and
attached to the myograph. Furthermore, prior to each
recording, the stimulation electrodes were placed again
above the nervus ulnaris, the amplitude of the supra-maxi-
mal stimulus was determined and the optimal muscle
length was noted down. Each experiment lasted approxi-
mately 20 minutes and the whole session 3 hours 20 min-
utes.
Reference interval: We examined 405 healthy test subjects.
The experimental conditions were the same with the ones
described for the reproducibility tests, except for a reduc-
tion in the number of force testings to two for each sub-
ject. Between the two examinations, the subject's
extremity was reattached to the apparatus and the optimal
muscle length was determined again.
Stimulation and recordings
The nervus ulnaris was stimulated at the level of the wrist,
using surface electrodes. For the study the musculus adduc-
tor pollicis was stimulated via the ulnar nerve at the level of
the wrist. Using this stimulation site at the radial side,
only two muscles are activated: the musculus adductor polli-
cis and the flexor pollicis brevis. Both muscles can be seen as
a functional association with the same origin, same inser-
tion and same physiological axis for the thumb move-
ment. Their contractions are completely transmitted to
the force sensor. At the ulnar side the ulnar nerve activates
some other muscles too, their contractions, however, are
buffered by the setting cushions and their contractions do
not contribute to the force output which is measured. The
stimulation was supra-maximal, with monophasic rectan-
gular waveform, had a duration of 0.1 ms and an ampli-
tude between 7 and 28 mA, thus ensuring that all motor
units of the musculus adductor pollicis were simultaneously
stimulated, once for each pulse. The recordings were car-
ried out in the same laboratory and in the same setting, at
a room temperature of 20–21°C.
Data Analysis
Statistical analysis was performed using analysis of vari-
ance for both measurements within a testing session and
between testing sessions. Post hoc discriminations were
made with the Bonferroni significance correction using
SPSS software. The reproducibility of muscle force was
determined by two-way analysis of variance, which made
it possible to discriminate between the force of the muscle
tested, usual fluctuations during a test period and a real
error of measurements.
Furthermore, a hierarchical variance analysis was carried
out using the following linear model: yijk = µ + pi + dij + eijk,
where: yijk is the reproducibility of measured muscle force
of observation ijk, µ is the overall mean, pi is the effect of
test-person j, dij is the effect of day ij (nested in test-person
i) and eijk is the residual effect connected with observation
ijk.
Analyses were performed for consecutive numbers of
observations from 10 to 2 within subclasses (test person,
day). The GLM procedure of SAS was used.BioMedical Engineering OnLine 2007, 6:49 http://www.biomedical-engineering-online.com/content/6/1/49
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Results
In the first part of the study, the muscle force calculated as
a mean of 10 datasets collected during one session was
9.13 – 13.24 N for men and and 6.87 – 8.05 N for women
(Fig. 1). The difference between the mean muscle force of
tested men and women (3 and 2 subjects, respectively)
was significant (P < 0.05). Furthermore, the results
obtained from the female subjects were more homoge-
nous during the test period, compared with the three
tested men.
Changes of measured muscle force between consecutive
sessions on each test subject were characterized using
mean value and standard deviation and compared using
analysis of variance. Interestingly, in some cases, in the 7th
session for men or in 5th and 7th sessions for women, an
increase in the mean force of muscle contraction was
found. In contrast to the increased variability of the mean
muscle force between test-subjects, the muscle force for a
given subject was very stable over the 10 sessions (Fig. 1).
The maximal absolute differences were between 0.3 to 0.9
N in the men and 0.2 N in the two women.
Important to notice is that the differences of muscle force
for the same test subject measured during one session
were small and not significant (Fig. 2). Thus the reproduc-
ibility of muscle force measured with the use of the myo-
graph was accurate. To determine the precision of the
device, standard deviations of results for each test-subject
and for each session of 10 tests were determined and the
mean value of all 50 standard deviations was calculated
(0.12 N) and divided by the mean value of the force for all
tests (9.53 N). The result, the coefficient of variation
(0.0126), indicates the precision of the measurements
(98.74%). Therefore, the whole error of the measure-
ments performed with the newly developed myograph
reaches only 1.3%.
Using a hierarchical variance analysis, the results obtained
for every test subject during one session were homoge-
nous enough to suggest that not more than two consecu-
tive measurements are needed in order to assess a real,
representative individual value of muscle force.
For the calculation of the reference interval, 810 force val-
ues from two consecutive measurements of 405 test sub-
jects were obtained. The mean value was 9.51 N, the
standard deviation +/- 2.42 N and the 95% reference
interval was 4.77 – 14.25 N.
Discussion
Precise quantitative measurements are necessary to assess
neuromuscular deficit, while accurate and sensitive meas-
urements are needed to document therapeutic efficacy
and/or to define the natural history of a disease [4]. Addi-
tionally, to monitor the progress of a disease and its
response to treatment, it is important to make sure that
the sensitivity of the tests is high enough to allow changes
to be detected. Clinicians normally rely on EMG or on
manual testing to examine muscle functions. While the
first method does not analyse muscle mechanics, the sec-
ond method relies on subjective assessment by the clini-
cian and is therefore inadequate to quantify small changes
in muscle strength. Up to now, no known device for
Reproducibility and variability of measured muscle force in  five test subjects examined 10 times at short time intervals  during the first session Figure 2
Reproducibility and variability of measured muscle force in 
five test subjects examined 10 times at short time intervals 
during the first session.
Muscle force (m. adductor pollicis) measured for 5 test sub- jects during 10 sessions Figure 1
Muscle force (m. adductor pollicis) measured for 5 test sub-
jects during 10 sessions. Every point represents the mean 
value of 10 measurements (± standard deviation). The mean 
muscle force obtained for test subjects varied between 12.2 
N and 7.2 N. The results of the three upper curves belong to 
three male test subjects and are less consistent (12.2 – 11.1 
N), in comparison with the muscle force registered for two 
female test subjects (mean values 6.87 and 8.05 N respec-
tively). a, b, ... mean values marked by the same superscripts 
are not significantly different for the same test subject (P ≤ 
0.05).BioMedical Engineering OnLine 2007, 6:49 http://www.biomedical-engineering-online.com/content/6/1/49
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mechanical muscle testing, no matter if it uses voluntary
or electrically stimulated contraction, can repeatedly
examine the muscle at its individual optimal length, due
to technical limitations of the setting and the pre-stretch-
ing mechanism [3-5,7].
Our myograph, however, can do this and may therefore
examine an in-vivo muscle under the same precise condi-
tions as a separated muscle in-vitro [16,17]. Its features
include a reproducible extremity setting with precise axle
adjustment, an infinitely adjustable pre-stretching mecha-
nism, and the ability to maintain constant conditions dur-
ing the experiment with a full transfer of the muscle force
to the sensor.
The primary purpose of the study was to investigate the
reproducibility of the results of measurements performed
on our myograph. To this purpose, the muscle force of 5
young test subjects was assessed over 10 sessions of 10
tests each. The measurements were performed on the mus-
culus adductor pollicis, which can be stretched in-vivo to its
optimal length and is one of the key-muscles for clinical
testing.
Focusing on the practical use of our myograph, we ana-
lyzed the variability of the muscle force measured within
one session and between consecutive sessions on the
same test subject. The reproducibility was so high, that
only two consecutive measurements would be needed in
order to collect objective data. The variability of muscle
force, measured as standard deviation (SD), was on aver-
age lower than 0.12 N during 10 sessions, which results
into a percentage change (expressed as SD × 100/mean) of
only of 1.3% when compared with a mean muscle force of
9.53 N. Although objective comparison to devices
described in the literature and those used in the clinical
setting represents a difficult challenge, the results
obtained with our myograph were more homogenous to
those obtained with other devices [2,6,7].
The assessment of muscle force is often used to determine
disease progression and, consequently, to assess the
results of the therapeutic interventions. A high degree of
reproducibility is essential for measurements across test-
ing sessions to ease the monitoring of the disease progres-
sion. In our study, measurements of muscle force were
very reproducible, confirming the quality and reproduci-
bility of the results obtained with our myograph. The
comparison to results described in literature is difficult,
since different methods were used and their technical
application allows fewer degrees of adjustment. Neverthe-
less, the precision of 98.64% in our measurements is
higher than the precision described so far in literature for
other devices. Brass et al. [11] described torque assess-
ment of two muscle groups in humans. The variability of
muscle force of adductor pollicis, calculated as the percent-
age difference between the second test relative to the first
one was 4.6% ± 4.7% (n = 7). Wang et al. reported a vari-
ability of 7% during measurements of maximal force for
the knee flexor and extensor within a single test ses-
sion[18]. The authors indicated that this was due to diffi-
culties in the standardization of the testing position and
thus of the muscle length. Measurements of maximal vol-
untary torque by Todd et al. [2] also displayed a variability
within a testing session (coefficient of variation range, 5–
11%). In some tests described in the literature, the quality
of measurements relied on the experience of the examin-
ers and was more stable when subjects maintained some
degree of physical activity [6]. This type of error for any
measuring device has two components: inaccuracies of
the measuring device and natural fluctuations in the force
of contraction during the same session. Natural fluctua-
tions occur for instance because surrounding muscular
and non muscular structures lead to inhomogeneous sar-
comer lengths, therefore the respective optimum muscle
lengths and the respective number of actin-myosin con-
nections in the muscle differ slightly between two consec-
utive examinations [19,20].
The substantial difference between our myograph and
other devices is the possibility to precisely examine the
individual muscle at its optimal length and to keep these
conditions constant during the test. Thus, data obtained
with the use of our myograph are valid independently of
the special examination procedure and device.
In comparison to the other devices, the high precision of
the newly developed myograph allows more efficient
measurement procedures, so that studies can be carried
out with fewer patients with less expense and also over a
shorter time period. Only two consecutive measurements
are required to obtain the same confidence as ten or more
measurements performed during a session.
The precise, reproducible and valid measurements per-
formed with our myograph and the successful definition
of reference values opens up a clinical access to the etiol-
ogy and the pathogenesis of nerve-muscle diseases. The
progression of the disease may be more closely monitored
and our device is sensitive enough to detect small differ-
ences or early deficits. If a general trend is defined, estima-
tions of the prognosis may be obtained. There is even the
possibility that therapies could be modified based on the
test results. Clinical studies with a prototype of this myo-
graph have begun on our intensive care unit. We monitor
partly concious, partly unconcious patients with either a
critical illness polyneuropathy or myopathy. Because this
disease affects many skeletal muscles we can take the mus-
culus adductor pollicis as a key muscle for the dis-
ease[21,22]. In diseases that affect only a few muscles, wePublish with BioMed Central    and   every 
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have to choose an appropriate setting module for the
selected muscle [16].
Conclusion
The new myograph is a highly reliable measuring device
with which the adductor pollicis can be investigated at the
optimum length. The results of this study on healthy sub-
jects provide a basis for the examination of nerve and
muscle function on patients. A study protocol can be
restricted to two consecutive measurements to assess the
function at a specific time point. The assessed physiologi-
cal reference interval may help to rate the grade of disabil-
ity.
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